« Return to News | CROs/Service Providers

LabConnect Reveals SciOps Support Team

Tuesday, October 30, 2012 09:53 AM
Seattle-based LabConnect has launched a new service, Scientific Operations Support (SciOps), to offer unique functional outsourcing services to the pharmaceutical research industry.
 
According to president and CEO Eric Hayashi, LabConnect developed SciOps after executives perceived a need from clients for a team that could manage intricate clinical protocols as well as internal and external research development programs.
 
“We knew that we needed to go beyond the traditional outsourcing services,” Hayashi said. “With SciOps, clients get exactly who they need from our contract personnel to take on specific projects and research functions.”
 
LabConnect’s SciOps team gives its clients management control from the beginning, without the time and cost strains of managing internal headcount, payroll and human resources issues. Unlike other outsourcing services, clients have access to tap into the expertise of the company’s senior personnel or specialists within the team to improve study quality and process flow.
 
In addition to routine testing, sample tracking, data management and specialized testing, LabConnect’s professional support at all levels provides clients the ability to select the services that best fit their needs and budget.
 
“The degree of integration with client operation often allows the SciOps team to make specific, objective recommendations for product and process improvement,” Hayashi said.
 
LabConnect’s SciOps team members each have a minimum of 10 years’ experience.
 
Privately held LabConnect provides global central laboratory testing services to the biopharmaceutical industry to support drug development programs around the world. Its capabilities include routine and specialized testing, safety, esoteric, bioanalytical, pathology and biostorage and logistics services.
Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.